What is she best known for?
The fields of study she is best known for:
The scientist’s investigation covers issues in Tuberculosis, Mycobacterium tuberculosis, Immunology, Pharmacology and Pharmacokinetics.
The concepts of her Tuberculosis study are interwoven with issues in Antibiotics, Lung and Linezolid.
Her Antibiotics research focuses on Lesion and how it connects with Moxifloxacin and Rifampicin.
The Mycobacterium tuberculosis study combines topics in areas such as Drug development, Drug resistance, Microbiology, In vivo and Drug discovery.
Her studies examine the connections between Immunology and genetics, as well as such issues in Latent tuberculosis, with regards to Clinical disease and Lesion progression.
Her Pharmacology research incorporates themes from Plasmodium falciparum, Spiroindolone and Plasmodium berghei.
Her most cited work include:
- The spectrum of latent tuberculosis: rethinking the biology and intervention strategies (945 citations)
- Spiroindolones, a Potent Compound Class for the Treatment of Malaria (801 citations)
- Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis (390 citations)
What are the main themes of her work throughout her whole career to date?
Véronique Dartois mainly investigates Tuberculosis, Mycobacterium tuberculosis, Pharmacology, Microbiology and Immunology.
The various areas that Véronique Dartois examines in her Tuberculosis study include Antibiotics and Drug resistance.
Her Mycobacterium tuberculosis study also includes fields such as
- In vivo that connect with fields like Drug discovery,
- Immune system which intersects with area such as Immunopathology.
Within one scientific family, Véronique Dartois focuses on topics pertaining to Plasmodium berghei under Pharmacology, and may sometimes address concerns connected to Plasmodium falciparum and Spiroindolone.
Her Microbiology study incorporates themes from Mycobacterium abscessus, Mycobacterium, Bacteria and Mutant.
Immunology is frequently linked to Latent tuberculosis in her study.
She most often published in these fields:
- Tuberculosis (47.06%)
- Mycobacterium tuberculosis (44.71%)
- Pharmacology (24.12%)
What were the highlights of her more recent work (between 2018-2021)?
- Tuberculosis (47.06%)
- Mycobacterium tuberculosis (44.71%)
- Pharmacology (24.12%)
In recent papers she was focusing on the following fields of study:
Her primary scientific interests are in Tuberculosis, Mycobacterium tuberculosis, Pharmacology, Microbiology and Pharmacokinetics.
Her Tuberculosis research integrates issues from Efficacy, Antibiotics and Potency.
Her research integrates issues of Pharmacophore, Computational biology, Drug resistance and Cephalosporin in her study of Mycobacterium tuberculosis.
Her study looks at the relationship between Drug resistance and fields such as Gene, as well as how they intersect with chemical problems.
She interconnects Antitubercular Agent, Laser capture microdissection and In vivo in the investigation of issues within Pharmacology.
Her Pharmacokinetics research is multidisciplinary, relying on both Metabolite, Gastroenterology and Delamanid.
Between 2018 and 2021, her most popular works were:
- Tuberculosis drugs’ distribution and emergence of resistance in patient’s lung lesions: A mechanistic model and tool for regimen and dose optimization (54 citations)
- Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance. (23 citations)
- Gut Microbiota Metabolite Indole Propionic Acid Targets Tryptophan Biosynthesis in Mycobacterium tuberculosis. (23 citations)
In her most recent research, the most cited papers focused on:
Her scientific interests lie mostly in Tuberculosis, Microbiology, Mycobacterium abscessus, Pharmacology and Pyrazinamide.
Her study in Tuberculosis is interdisciplinary in nature, drawing from both Potency, Frameshift mutation, Phase variation, Drug tolerance and Gene.
Her Microbiology research is multidisciplinary, incorporating perspectives in Fatty acid, Mycobacterium tuberculosis, Innate immune system, Reversion and Virulence.
Her Mycobacterium tuberculosis research is multidisciplinary, incorporating elements of NADPH oxidase, Xenophagy, Immune system, Intracellular parasite and Beta oxidation.
Her research in Pharmacology intersects with topics in Statin and Adjunctive treatment.
Her Pyrazinamide study combines topics from a wide range of disciplines, such as Lesion, Gastroenterology, Regimen, Internal medicine and Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
